Scholar Rock
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Massachusetts, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
301 Binney St Ste 3, Cambridge, Massachu...Phone Number
(857) 259-3860Website
www.scholarrock.comRevenue
-Stock Symbol
SRRKIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Scholar Rock
Scholar Rock is a clinical-stage biopharmaceutical company specializing in the discovery and development of medicines and the treatment of serious diseasesExplore more
Scholar Rock Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Scholar Rock your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Scholar Rock has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Scholar Rock had a recent Job posting/layoffs
Check out if Scholar Rock is spiking on competitors!
Scholar Rock, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Scholar Rock has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Scholar Rock
Earning: See what the market has to say on Scholar Rock recently announced quarterly report
Product Launch: Get notified when Scholar Rock launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Scholar Rock
Find more new buyers
Compare Similar Companies to Scholar Rock
Compare insights from companies similar to Scholar Rock, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$191.6M
201-500
Private
$300M
2017
PP
Pamela Papino-WoodGlobal Vice President, Medical Operations & Excellence
$38.1M
51-200
Public
$345.9M
2009
JH
Jill HopkinsChief Medical Officer & President, Research & Development
Company Profile Activity
Activity Insights
Scholar Rock is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Scholar Rock is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Scholar Rock.
Scholar Rock financials insights
Gather financial insights about Scholar Rock, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Series A
$20M
2016
Series B
$36M
2018
Series C
$47M
Stock Offering
$86.3M
2019
Stock Offering
$51.8M
2020
Debt
$50M
Stock Offering
$230M
2022
Stock Offering
$205M
Scholar Rock Tech Stack
A closer look at the technologies used by Scholar Rock
Most Recent Scoops
Person-Based
Pharmaceuticals
Person-Based
Pharmaceuticals
Open Position
Open Position
Open Position
Scholar Rock News & Media
Kuehn Law Encourages Investors of Scholar Rock Holding Corp to Contact Law Firm
NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Scholar Rock Holding Corp (NASDAQ: SRRK) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.Scholar Rock Holding Corporation (SRRK) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Scholar Rock Holding Corporation (SRRK) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 9, 2026 10:00 AM EDTCompany ParticipantsDavid...Scholar Rock Q1 Earnings Call Highlights
Scholar Rock (NASDAQ:SRRK) said the U.S. Food and Drug Administration has accepted for review its resubmitted Biologics License Application for apitegromab, the company’s investigational treatment for children and adults with spinal muscular atrophy, and set a PDUFA action date of Sept. 30, 2026. CScholar Rock Holding Corporation (SRRK) Q1 2026 Earnings Call Transcript
Scholar Rock Holding Corporation (SRRK) Q1 2026 Earnings Call May 7, 2026 8:00 AM EDTCompany ParticipantsLaura EkasDavid Hallal - CEO & Chairman of the...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Scholar Rock
Sign Up For FreeTo access detailed company insights
Scholar Rock is a clinical-stage biopharmaceutical company specializing in the discovery and development of medicines and the treatment of serious diseases... Read More
